Introduction: Clear guidelines for colorectal lung metastasis (LM) treatment are not available. This study aimed to provide insight into the treatment strategies and efficacy of local and systemic therapy in patients with LM eligible for (potentially) curative treatment. Methods: This was a retrospective study of patients with ≤5 LM discussed in two tertiary referral centers. Patient and tumor characteristics were compared between treatment groups. Treatment strategies were compared between centers and survival data between treatment groups, local treatment modalities, and treating centers. Results: Ninety-two patients (median 2 LMs) were included. Seventy-one (77%) patients underwent local treatment (17 surgery, 13 ablation, 38 radiotherapy, 3 combination of local treatments) and 21 (23%) with systemic therapy alone. The latter group more frequently had extrapulmonary metastases (81.0% vs. 26.8%, p < 0.001) and synchronous presentation of LM (23.8% vs. 7.0%, p = 0.045). Choice of local versus systemic therapy and time to start treatment after diagnosis (median 109 days, IQR 44–240 vs. 88 days, IQR 53–168) were comparable between centers. Three-year survival rates did not differ between treatment groups, local treatment modalities, or treating centers. Conclusion: Treatment strategies and oncological outcomes were rather similar between centers. Survival outcomes were not different between locally and systemically treated patients.

1.
Mitry
E
,
Guiu
B
,
Cosconea
S
,
Jooste
V
,
Faivre
J
,
Bouvier
AM
.
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
.
Gut
.
2010
;
59
(
10
):
1383
8
.
2.
Nordholm-Carstensen
A
,
Krarup
PM
,
Jorgensen
LN
,
Wille-Jørgensen
PA
,
Harling
H
,
Danish Colorectal Cancer Group
.
Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: a nationwide cohort study
.
Eur J Cancer
.
2014
;
50
(
2
):
447
56
.
3.
Van Cutsem
E
,
Cervantes
A
,
Adam
R
,
Sobrero
A
,
Van Krieken
JH
,
Aderka
D
, et al
.
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
.
Ann Oncol
.
2016
;
27
(
8
):
1386
422
.
4.
Ibrahim
T
,
Tselikas
L
,
Yazbeck
C
,
Kattan
J
.
Systemic versus local therapies for colorectal cancer pulmonary metastasis: what to choose and when
.
J Gastrointest Cancer
.
2016
;
47
(
3
):
223
31
.
5.
Li
J
,
Yuan
Y
,
Yang
F
,
Wang
Y
,
Zhu
X
,
Wang
Z
, et al
.
Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)
.
J Hematol Oncol
.
2019
;
12
(
1
):
16
.
6.
Filippi
AR
,
Guerrera
F
,
Badellino
S
,
Ceccarelli
M
,
Castiglione
A
,
Guarneri
A
, et al
.
Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer
.
Clin Oncol
.
2016
;
28
(
8
):
505
12
.
7.
Lodeweges
JE
,
Klinkenberg
TJ
,
Ubbels
JF
,
Groen
HJM
,
Langendijk
JA
,
Widder
J
.
Long-term outcome of surgery or stereotactic radiotherapy for lung oligometastases
.
J Thorac Oncol
.
2017
;
12
(
9
):
1442
5
.
8.
Hiyoshi
Y
,
Miyamoto
Y
,
Kiyozumi
Y
,
Sawayama
H
,
Eto
K
,
Nagai
Y
, et al
.
CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer
.
Int J Clin Oncol
.
2019
;
24
(
3
):
288
95
.
9.
Treasure
T
.
Surgery and ablative techniques for lung metastases in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) trial: is there equivalence
.
J Thorac Dis
.
2016
;
8
(
Suppl 9
):
S649
s651
.
10.
Dindo
D
,
Demartines
N
,
Clavien
PA
.
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey
.
Ann Surg
.
2004
;
240
(
2
):
205
13
.
11.
Cox
JD
,
Stetz
J
,
Pajak
TF
.
Toxicity criteria of the radiation therapy Oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)
.
Int J Radiat Oncol Biol Phys
.
1995
;
31
(
5
):
1341
6
.
12.
Treasure
T
,
Farewell
V
,
Macbeth
F
,
Batchelor
T
,
Milošević
M
,
King
J
, et al
.
The Pulmonary Metastasectomy in Colorectal Cancer cohort study: analysis of case selection, risk factors and survival in a prospective observational study of 512 patients
.
Colorectal Dis
.
2021
;
23
(
7
):
1793
803
.
13.
Kim
CH
,
Huh
JW
,
Kim
HJ
,
Lim
SW
,
Song
SY
,
Kim
HR
, et al
.
Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer
.
Dis Colon Rectum
.
2012
;
55
(
4
):
459
64
.
14.
Milosevic
M
,
Edwards
J
,
Tsang
D
,
Dunning
J
,
Shackcloth
M
,
Batchelor
T
, et al
.
Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients – control survival is much better than previously assumed
.
Colorectal Dis
.
2020
;
22
(
10
):
1314
24
.
15.
Cao
C
,
Wang
D
,
Tian
DH
,
Wilson-Smith
A
,
Huang
J
,
Rimner
A
.
A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases
.
J Thorac Dis
.
2019
;
11
(
12
):
5187
98
.
16.
Zhong
J
,
Palkhi
E
,
Ng
H
,
Wang
K
,
Milton
R
,
Chaudhuri
N
, et al
.
Long-term outcomes in percutaneous radiofrequency ablation for histologically proven colorectal lung metastasis
.
Cardiovasc Intervent Radiol
.
2020
;
43
(
12
):
1900
7
.
17.
Choi
HS
,
Jeong
BK
,
Kang
KM
,
Jeong
H
,
Song
JH
,
Ha
IB
, et al
.
Tumor control and overall survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer: a meta-analysis
.
Cancer Res Treat
.
2020
;
52
(
4
):
1188
98
.
18.
Pfannschmidt
J
,
Dienemann
H
,
Hoffmann
H
.
Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series
.
Ann Thorac Surg
.
2007
;
84
(
1
):
324
38
.
19.
Gonzalez
M
,
Gervaz
P
.
Risk factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis
.
Future Oncol
.
2015
;
11
(
2 Suppl l
):
31
3
.
20.
Nelson
DB
,
Tayob
N
,
Nguyen
QN
,
Erasmus
J
,
Mitchell
KG
,
Hofstetter
WL
, et al
.
Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases
.
J Thorac Cardiovasc Surg
.
2019
;
158
(
4
):
1234
41.e16
.
21.
Schlijper
RC
,
Grutters
JPC
,
Houben
R
,
Dingemans
AMC
,
Wildberger
JE
,
Van Raemdonck
D
, et al
.
What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation
.
Cancer Treat Rev
.
2014
;
40
(
1
):
60
7
.
22.
Ninomiya
M
,
Nakajima
J
,
Tanaka
M
,
Takeuchi
E
,
Murakawa
T
,
Fukami
T
, et al
.
Effects of lung metastasectomy on respiratory function
.
Jpn J Thorac Cardiovasc Surg
.
2001
;
49
(
1
):
17
20
.
23.
Delpla
A
,
de Baere
T
,
Varin
E
,
Deschamps
F
,
Roux
C
,
Tselikas
L
.
Role of thermal ablation in colorectal cancer lung metastases
.
Cancers
.
2021
;
13
(
4
):
908
.
24.
Leaman-Alcibar
O
,
Cigarral
C
,
Déniz
C
,
Romero-Palomar
I
,
Navarro-Martin
A
.
Quality of life after stereotactic body radiation therapy versus video-assisted thoracic surgery in early stage non-small cell lung cancer. Is there enough data to make a recommendation
.
J Clin Transl Res
.
2021
;
7
(
2
):
209
20
.
You do not currently have access to this content.